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Introduction: Exsanguination due to trauma-induced coagulopathy is a continuing challenge in emergency trauma
care. Fibrinogen is a crucial factor for haemostatic competence, and may be the factor that reaches critically low
levels first. Early fibrinogen substitution is advocated by a number of authors. Little evidence exists regarding the
indications for fibrinogen supplementation in the acute phase. This study aims to estimate the prevalence of
hypofibrinogenaemia in a multi-center trauma population, and to explore how initial fibrinogen concentration
relates to outcome. Also, factors contributing to low fibrinogen levels are identified.
Methods: Patients arriving in hospital less than 180 minutes post-injury requiring full trauma team activation in four
different centers were included in the study. Time from injury, patient demographics, injury severity scores (ISS) and 28
days outcome status were recorded. Initial blood samples for coagulation and blood gas were analyzed. Generalized
additive regression, piecewise linear regression, and multiple linear regression models were used for data analyses.
Results: Out of 1,133 patients we identified a fibrinogen concentration ≤1.5g/L in 8.2%, and <2 g/L in 19.2%. A non-linear
relationship between fibrinogen concentration and mortality was detected in the generalized additive and piecewise linear
regression models. In the piecewise linear regression model we identified a breakpoint for optimal fibrinogen concentration
at 2.29 g/L (95% confidence interval (CI): 1.93 to 2.64). Below this value the odds of death by 28 days was reduced by a
factor of 0.08 (95% CI: 0.03 to 0.20) for every unit increase in fibrinogen concentration. Low age, male gender, lengthened
time from injury, low base excess and high ISS were unique contributors to low fibrinogen concentrations on arrival.
Conclusions: Hypofibrinogenaemia is common in trauma and strongly associated with poor outcome. Below an
estimated critical fibrinogen concentration value of 2.29 g/L a dramatic increase in mortality was detected. This finding
indicates that the negative impact of low fibrinogen concentrations may have been previously underestimated. A number
of clinically identifiable factors are associated with hypofibrinogenaemia. They should be considered in the management
of massively bleeding patients. Interventional trials with fibrinogen substitution in high-risk patients need to be undertaken.Introduction
Despite the implementation of damage control resuscita-
tion principles, exsanguination remains a frequent cause of
death in hospital [1,2]. Early coagulopathy is identified in
10 to 34% of patients arriving in hospital and is associated
with increased mortality [3]. Fibrinogen plays a pivotal* Correspondence: jostein.hagemo@snla.no
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reproduction in any medium, provided the orrole in coagulation as it is converted into fibrin, which
in conjunction with platelets forms a stable blood clot as
the end haemostatic product [4]. Low fibrinogen levels or
inefficient fibrinogen utilisation may adversely impact on
patient outcomes.
Besides low fibrinogen levels due to blood loss and
increased consumption, a number of factors affect fibrino-
gen metabolism in a massively bleeding trauma patient.
Hypothermia reduces fibrinogen synthesis [5] whereas
acidaemia following hypoperfusion leads to increasedal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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crystalloid fluids and reduced fibrin inter-linkage by
synthetic colloids has been demonstrated [7]. In addition
to reduced fibrinogen availability, there are indications
that fibrinogen utilisation is reduced in patients with
trauma coagulopathy. This finding is associated with
increased levels of soluble thrombomodulin and increased
protein C activation [8,9].
The role of fibrinogen in massively bleeding trauma
patients has been subject to increasing interest over the
past few years. However, little evidence exists regarding
the incidence of hypofibrinogenaemia and the factors
that contribute to it. Several authors suggest a possible
benefit from an earlier and more aggressive fibrinogen
substitution strategy [7,10-13]. Current European guide-
lines recommend fibrinogen substitution at fibrinogen
concentrations less than 1.5 to 2.0 g/l during uncon-
trolled bleeding [14]. Fibrinogen supplementation can be
achieved by administering cryoprecipitate, fresh frozen
plasma or fibrinogen concentrate, but levels of evidence
to indicate the optimal source or schedule for fibrinogen
supplementation in trauma are poor [10]. Measurement of
fibrinogen concentration by conventional methods is time
consuming and may delay necessary fibrinogen adminis-
tration. Point-of-care assessments of haemostasis such as
thrombelastography and thrombelastometry may provide
more rapid indicators of the need for treatment [15].
The purpose of this multicentred international study
was to estimate the prevalence of hypofibrinogenaemia
in the initial phase after traumatic injury and to explore
how the initial fibrinogen concentration relates to mortal-
ity in trauma patients. We also aimed to identify factors
contributing to low fibrinogen levels.
Materials and methods
Patient selection and data collection
Data were collected from trauma patients admitted over
a 2-year period from 1 March 2008 to 28 February 2010
in four different trauma centres (San Francisco General
Hospital, USA; Royal London Hospital, UK; Radcliffe
Hospital, UK; Oslo University Hospital, Norway). Criteria
for inclusion were patients 18 years or older initiating full
trauma team response in accordance with internationally
accepted criteria for major trauma centres. Patients were
excluded if the time from injury to arrival exceeded 180
minutes or was not known. All data were collected
prospectively as part of an observational study, except
for Oslo where data were retrieved from The Oslo
University Hospital Trauma Registry. The study was
performed in accordance with ethical regulations in the
respective centres (see Acknowledgements). All patients
included prospectively gave their consent to participate
in the study. For patients included retrospectively, an
exemption from informed consent was approved by thelocal Privacy and Data Protection Officer. Data collected
included: age, gender, mechanism of injury, Injury Severity
Score (ISS), the maximum Abbreviated Injury Scale (AIS)
score per ISS body region, time from injury and 28-day
survival. Along with fibrinogen concentration, the Inter-
national Normalized Ratio (INR) and platelet count are
known predictors of massive transfusion and mortality
[16,17], and were therefore also included in the analyses.
Base excess (BE) was collected as a surrogate marker of
hypoperfusion, which in the trauma setting is highly corre-
lated to blood loss [18].
Sampling methods
Arterial blood samples for fibrinogen concentration, INR
and platelet count were collected in citrated tubes.
Heparinised syringes were used for BE sampling. All
samples were collected shortly after arrival in the trauma
room and were analysed without delay. Fibrinogen con-
centration was analysed by the Clauss method, and a
value ≤1.5 g/l was defined as hypofibrinogenaemia. Pro-
thrombin time was converted to the INR in accordance
with the analytical system of each respective laboratory.
BE was determined by conventional blood gas analysers.
In this study we defined patients with BE less than –5.0
mEq/l as hypoperfused.
Statistical methods
Summary data are presented as number (percentage) and
mean (standard deviation) or median (quartiles) where
appropriate. The AIS and ISS were treated as continuous
variables. Student’s t test was applied for comparison of
fibrinogen concentrations in groups based on outcome.
To explore the initial fibrinogen concentration as a
predictor of 28-day mortality, we fitted a multiple logistic
regression model, adjusting for the following covariates:
ISS, age, time from injury, BE, INR, platelet count, gender
and mechanism of injury.
Several of the independent variables, among them the
initial fibrinogen concentration, were suspected to have
a nonlinear relationship with the dependent variable [19].
In addition to a standard multiple logistic regression
model, we thus also fitted a piecewise linear regression
model [20] and a generalised additive regression model
(GAM) [21]. These three regression models represent
increasing levels of flexibility in the functional relation-
ship between the dependent and independent variables.
The standard logistic regression model assumes a linear
relationship between the independent variable and the
dependent variable over the whole range of the observed
values for the independent variables. Piecewise linear
models, on the other hand, refine this approach by assum-
ing a series of linear segments and accompanying break-
points. Finally, the GAM is a generalisation of generalised
linear models and imposes minimal restrictions on the
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and the dependent variable by fitting a suitable spline
function; that is, a set of polynomials. The optimal spline
was chosen using cross-validation [21]. We used Akaike’s
Information Criterion to compare the different regression
models [22].
To identify possible predictors of low fibrinogen con-
centration we fitted two multiple linear regression models
with fibrinogen concentration as the dependent variable.
In the first model, BE, time from injury, age, gender and
ISS were entered as independent variables. In the second
model, ISS was replaced by separate AIS scores for the
five different ISS body regions: head and neck; face;
chest; abdomen and pelvic contents; and extremities
and pelvic girdle.
All statistical analyses were performed using R 2.15/
3.0.0 (R Core Team, 2013; R Foundation for Statistical
Computing, Vienna, Austria). Results from the three mul-
tiple logistic regression models are presented as the
odds ratio (OR) (95% confidence interval). For the linear
multiple regressions, results are presented as standardised
β coefficients (95% confidence interval). P < 0.05 was
considered statistically significant.Results
A total of 1,133 patients from the four centres were
included. Descriptive data for the study population are
presented in Table 1. Hypofibrinogenaemia (≤1.5 g/l) was
identified in 93 (8.2%) of the patients. Fibrinogen concen-
tration less than 2.0 g/l was found in 211 (19.2%) patients.
The mean (standard deviation) fibrinogen concentration
on arrival was 2.68 (0.75) g/l for 28-day survivors and 1.95
(1.21) g/l for nonsurvivors (P < 0.001).
The fitted functional association between fibrinogen
concentration and mortality rates using the GAM and theTable 1 Descriptive data for the study population
Total Base excess
less than −5
Number of patients 1,133 177
Age (years)a 37.2 (24.7, 49.7) 37.0 (24.5, 49.5)
Gender (% male) 76.3 76.8
Mechanism of injury (% blunt) 88.3 78.5
Injury Severity Score 16.1 (14.2) 28.9 (16.0)
Base excess (mEq/l) –2.48 (4.29) −9.82 (4.6)
International Normalized Ratio 1.11 (0.24) 1.19 (0.22)
Platelet count (109/l) 233.3 (64.4) 225.4 (77.0)
Fibrinogen (g/l) 2.62 (0.83) 2.05 (0.94)
Time from injury (minutes) 65.4 (37.7) 70.1 (38.8)
Survival (%) 91.3 72.7
Values presented as mean (standard deviation). aPresented as median (quartiles).piecewise linear regression model is depicted in Figure 1a.
We observe that a traditional linear logistic regression
model is inadequate, and that a model allowing for a
change in OR across the observed range of fibrinogen
concentrations is needed. Measured by Akaike’s Informa-
tion Criterion, the GAM is the best of the fitted models.
However, a piecewise linear regression model also has
strong support in the data. A traditional logistic regression
model has no support in the data. Figure 1b shows the
corresponding OR for the GAM and for the piecewise
linear model. Compared with the GAM, the piecewise
linear logistic regression model is more intuitively inter-
preted for clinical purposes, and is summarised in Table 2
along with results from the traditional linear logistic
regression model for comparison.
A statistically significant breakpoint for the association
between fibrinogen concentration and mortality was found
at a fibrinogen concentration of 2.29 g/l (1.93, 2.64). In the
segment below this breakpoint, the OR for mortality was
0.08 (0.03, 0.20); that is, a 90% reduction of the odds of
mortality for each unit increase in fibrinogen concentra-
tion. In the segment above the breakpoint, the relationship
was not significantly different from zero.
A nonlinear relationship with mortality was found also
for ISS in our data. A breakpoint was identified for ISS at
25.7 (21.8, 29.7). ORs for mortality were 1.18 (1.10,1.27)
for the lower segment and 0.93 (0.89, 0.97) for the upper
segment.
In the multiple linear regression model with fibrinogen
concentration as the dependent variable, the BE, time
from injury, age, gender, and ISS were all statistically
significant independent variables (Table 3, ISS model).
In the second model, where the ISS was replaced by
the five separate ISS body region scores, all regions
were significant predictors (Table 3, AIS model). In a
subgroup of subjects presenting with hypoperfusion,
extremities and pelvic girdle was the only ISS body region
group found to independently contribute significantly
to fibrinogen concentration with an unstandardised co-
efficient of –0.146 (P = 0.002).
Discussion
Key findings from this study include the wide variability in
presentation of fibrinogen concentrations, but critically
that 8.2% of the patients presented with hypofibrino-
genaemia defined as fibrinogen concentration ≤1.5 g/l on
admission. There was a strong association between low
fibrinogen values and mortality. In our population, survival
decreased dramatically with an OR of 0.08 as fibrinogen
concentration fell below 2.29 g/l. Risk factors for low
fibrinogen concentration were low BE, increasing time
from injury, young age, male gender and increasing
injury severity. Among injuries in different body regions, a
strong contributor to low fibrinogen concentration was
Figure 1 Multivariable generalised additive model and piecewise linear model for relationship between fibrinogen concentration and
28-day survival. Results from the multivariable generalised additive model (GAM) and the piecewise linear model for the relationship between
fibrinogen concentration and 28-day survival, adjusted for Injury Severity Score, age, time from injury, mechanism of injury, base excess, International
Normalized Ratio, platelet count and gender. The functional relationship is clearly nonlinear (a), resulting in a corresponding nonconstant odds ratio across
the observed range of fibrinogen values (b). For the piecewise linear model, the breakpoint (95% confidence interval (CI)) is estimated at 2.29 (1.93, 2.64).
Table 2 Linear and piecewise linear multiple logistic regression models with 28-day mortality as the dependent variable
Linear model Piecewise linear model
Odds ratio v P value Segment Odds ratio (95% CI) P value
Fibrinogen (g/l)a 0.46 < 0.001 Lower 0.08 < 0.001
(0.03, 0.20)(0.31, 0.67)
Upper 1.77 0.076
(0.94, 3.32)
Injury severity scoreb 1.03 0.008 Lower 1.18 < 0.001
(1.10, 1.27)(1.01, 1.05)
Upper 0.93 0.001
(0.89, 0.97)
Age (years) 1.05 < 0.001 1.04 < 0.001
(1.03, 1.06) (1.02, 1.06)
Time from injury (minutes) 0.99 0.166 0.99 0.018
(0.99, 1.00) (0.98, 1.00)
Mechanism of injury (penetrating) 0.73 0.546 0.33 0.06
(0.25, 1.90) (0.10, 1.05)
Base excess (mEq/l) 0.90 < 0.001 0.92 0.002
(0.85, 0.95) (0.87, 0.97)
International normalized ratio 3.21 0.012 1.65 0.29
(1.33, 8.53) (0.65, 4.18)
Platelet count (109/l) 1.00 0.61 1.00 0.92
(1.00, 1.00) (1.00, 1.00)
Gender (male) 0.45 0.006 0.33 0.001
(0.26, 0.81) (0.18, 0.62)
aBreakpoint for fibrinogen is 2.29 g/l (95% confidence interval (CI): 1.93, 2.64). bBreakpoint for Injury Severity Score is 25.7 (95% CI: 21.8, 29.7).
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Table 3 Linear regression of factors affecting fibrinogen concentration
ISS model AIS model
β (95% CI) P value β (95% CI) P value
Base excess (mEq/ml) 0.19 < 0.001 0.20 < 0.001
(0.14, 0.26)(0.13, 0.25)
Time from injury (minutes) –0.14 < 0.001 –0.12 < 0.001
(–0.18, –0.07)(–0.19, –0.08)
Age (years) 0.27 < 0.001 0.26 < 0.001
(0.21, 0.31)(0.22, 0.32)
Gender (male) –0.19 0.003 –0.19 0.004
(–0.31, –0.06)(–0.31, –0.06)
Injury Severity Score –0.27 < 0.001
(–0.33, –0.21)
Head and neck –0.11 < 0.001
(–0.17, –0.06)
Face –0.07 0.018
(–0.12, –0.01)
Thorax –0.07 0.035
(–0.12, –0.00)
Abdomen and pelvic contents –0.09 0.002
(–0.14, 0.03)
Extremities and pelvic girdle –0.17 < 0.001
(–0.22, –0.11)
AIS, Abbreviated Injury Scale; β, standardised coefficient; CI, confidence interval; ISS, Injury Severity Score.
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pelvic girdle.
Current European guidelines for massive haemorrhage
following trauma recommend a threshold for substituting
fibrinogen at concentrations below 1.5 to 2.0 g/l [14]. The
evidence underpinning this practice is very limited and is
largely drawn from elective surgery and postpartum haem-
orrhage, which may not be extrapolated to the trauma
setting. Our study identifies a breakpoint for initial fibrino-
gen concentration around 2.29 g/l, below which the odds
of death within 28 days is reduced by a factor of 0.08 for
every unit increase in fibrinogen concentration. GAM
analysis in the group of patients with fibrinogen concen-
trations above the breakpoint indicates that mortality
tends to increase with increasing fibrinogen concentration
(Figure 1a). The confidence interval in this segment is
relatively wide and results should be interpreted with
caution. Moreover, this relationship was not found to
be significant in the piecewise linear regression model.
The association between fibrinogen concentration and
mortality has recently been studied by Rourke and col-
leagues [23]. In a linear regression model they identified
an estimated OR of 0.22 for 28-day mortality, slightly
lower than in our population with an OR of 0.46. The
OR in the linear regression model in our study wassignificantly different from the lower segment of the
piecewise linear regression model with an OR of 0.08
(Table 2). The discrepancy between the linear and
piecewise linear regression models indicates that the
negative impact of hypofibrinogenaemia in trauma previ-
ously may have been underestimated.
The association between fibrinogen concentrations
and mortality in our study is in accordance with the
findings of Hess and colleagues [19], who demonstrated an
increased mortality in subjects with hypofibrinogenaemia,
with a comparable curved association between fibrinogen
concentration and survival. A possible explanation for the
increased mortality in the high fibrinogen concentration
group may be the development of thrombotic complica-
tions during the post-resuscitation phase [24]. A causative
relationship between high fibrinogen levels and post-
traumatic thrombotic events, however, is not well estab-
lished. In fact, a prophylactic infusion of 2 g fibrinogen was
shown not to trigger postoperative clinically detectable
thromboembolic events in patients undergoing cardiac
surgery in a randomised study by Karlsson and col-
leagues [25]. Despite a transient increase in fibrinogen
concentration after infusion and a subsequent reduced
blood loss, haemostatic parameters did not differ signifi-
cantly between groups after 24 hours.
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mortality in the high fibrinogen group may be related
to the fact that fibrinogen is an acute phase protein
indicating pre-existing inflammatory disease [26]. High
fibrinogen levels are associated with, for example, athero-
sclerotic disease, which may have been a confounding
factor in our analyses [27].
The observation that ISS, age and BE are predictors of
mortality in trauma is previously well documented [18,28].
Applying piecewise linear regression, we found a positive
linear association between the ISS score and mortality for
ISS scores <26. Surprisingly, a slight negative association
was found for ISS scores above this breakpoint. This result
should, however, be interpreted with caution. A few survi-
vors with very high ISS scores might have biased the effect
estimate of this upper segment. A selection bias due to
death before reaching inclusion in the study may also
have affected the results in the group of most severely
injured patients.
Increased INR is also previously documented to be
related to mortality [17]. This association was not
found to be significant in our study when adjusting for
fibrinogen concentration in a piecewise linear model.
Platelet count was not found to be an independent pre-
dictor of survival when adjusting for fibrinogen concentra-
tion in either model. This finding is in accordance with
previous studies showing that the apparent relationship
between platelet count and mortality becomes insignifi-
cant when other coagulation parameters are adjusted
for [29,30]. Interestingly, increased survival is reported
using a high platelet to red blood cell transfusion ratio
compared with lower ratios in trauma patients [31]. This
may indicate that not only platelet count, but also platelet
function must be taken into consideration [32].
Our analysis of factors contributing to low fibrinogen
concentrations demonstrated an association between time
from injury and fibrinogen concentration on arrival, even
when adjusting for measures of hypoperfusion. One
explanation for this association may be the lengthened
time frame for the increased consumptive process of
fibrinogen previously described in animal studies, regard-
less of hypothermia and acidosis [6,33].
Young age and male gender were also associated with
lower fibrinogen levels in our study population. The fi-
brinogen concentration in healthy individuals increases
with age in both men and women. Females of repro-
ductive age tend to have higher fibrinogen levels than
men of the same age, whereas men over the age of 60
have higher levels than women of the same age [34].
The majority of the subjects in our study was below the
age of 40, and thus a negative association between male
gender and fibrinogen concentration is expected.
Our data identified injury to the extremities and pelvic
girdle among the body regions as a strong contributor tohypofibrinogenaemia, such that in the subgroup of hypo-
perfused patients this was the only type of injury that
uniquely contributed to low fibrinogen levels. The impact
on coagulation of major orthopaedic trauma including
procedures involving intramedullary reaming and nailing
has been described [35,36] and may be related to intrava-
sation of procoagulant medullary fat and bone marrow.
Increased levels of thrombin–antithrombin complexes on
admission after orthopaedic injury have been demonstrated,
paralleled by increased levels of tissue plasminogen activa-
tor, as a marker of increased fibrinolysis [35]. Fat emboli
from the site of injury may also activate coagulation and
fibrinolysis in the pulmonary capillaries [37-39].
Our study has some limitations in addition to its partly
retrospective nature. Inclusion criteria were not strictly
defined, and minor differences between centres may have
occurred. Characteristics of the included cohort, however,
are reflected in the ISS and clinical markers of injury
(Table 1). The body core temperature on admission was
missing in a large number of the patients, and was there-
fore not included in the analyses. Hypothermia is known
to reduce fibrinogen synthesis, and the lack of data might
have influenced our regression models. On the other hand,
the normal acute phase response of fibrinogen synthesis is
only evident hours and days after exposure [36]. Within
the relatively short time frames in this study, the impact of
reduced fibrinogen synthesis is less significant. We did not
include data on prehospital fluid administration in this
study. The dilutional effect of administered fluids may
have reduced the fibrinogen concentration throughout
the prehospital phase. A restrictive prehospital fluid regi-
men is applied in all centres, however, and the potential
bias of fluid administration is therefore limited. All centres
used the Clauss method to measure fibrinogen concentra-
tion. Administration of colloid expanders may overesti-
mate fibrinogen concentration measured by this method
[40]. Colloids are extremely rarely used in the prehospital
setting in all the four centres, however, and are unlikely to
have imposed a systematic bias.
Conclusions
Our study demonstrates a significant proportion of trauma
patients with low fibrinogen levels on arrival in hospital.
Fibrinogen concentration on arrival below an estimated
threshold value of 2.29 g/l is strongly related to poor
outcome. Injuries to the extremities and pelvic girdle, a
low BE, long prehospital times, young age and male
gender appear to be associated with lower fibrinogen
concentrations. These factors should be considered in
the early management of exsanguinating patients. The
role of fibrinogen supplementation, and identification
of subgroups of patients that may benefit from this
treatment strategy, should be addressed in new inter-
ventional trails.
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 Low concentrations of fibrinogen on admission are
frequently observed in trauma patients.
 There is a nonlinear relationship between fibrinogen
concentrations and 28-day mortality, with a dramatic
increase in mortality below a fibrinogen concentration
breakpoint value of 2.29 g/l (95% confidence interval:
1.93,2.64).
 Low age, low BE, male gender, high ISS and
lengthened time from injury are unique predictors
for low fibrinogen concentrations.
 Interventional trials on fibrinogen substitution are
recommended.
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